Vaccine manufacturing 2

Published on May 31, 2015   39 min

You are viewing a talk that is a part of one of our comprehensive courses. Additional learning material: case studies, projects, workshops and recommended reading; multiple choice questions and suggested exam questions with model answers are available on application. Learn more

Other Talks in the Series: Vaccines

Is another kind of topic that has caused vaccine manufacturers and other biopharmaceutical manufacturers a great deal of difficult. Over, say, the last 30 or 40 years, especially in vaccine business since it first got born as a major worldwide activity, a lot of things have changed. We have enormously better scientific understanding. We know about the pathogen. We know about protective epitopes. We know exquisitely about molecular biology and immunology. We know huge amounts about bio-chemical engineering. And if we put all this knowledge together, we can apply it to make new vaccines, and we can do it fearlessly, and with success because we know what we're doing. On the other hand, there's a strong tendency in the industry to retain traditional methods of manufacturing thinking that like making wine some characteristic of the vaccine is imparted by the tradition and is beyond the scope of modern science.